Expanding the scope and visibility of ambulatory stewardship programs with novel coronavirus disease 2019 (COVID-19) therapeutics
Antimicrobial stewardship programs (ASPs) can be expanded to the outpatient setting to serve as a first line of defense against coronavirus disease 19 (COVID-19) hospitalizations and to reduce the burden on emergency departments and acute-care hospitals. Given the numerous emergency use authorizatio...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Cambridge University Press,
2022-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c09c7d8a80e64884a0e88eba8cf5e006 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Hongkai Bao |e author |
| 700 | 1 | 0 | |a Yi Guo |e author |
| 700 | 1 | 0 | |a Mei H. Chang |e author |
| 700 | 1 | 0 | |a Terrence McSweeney |e author |
| 700 | 1 | 0 | |a Austin M. Golia |e author |
| 700 | 1 | 0 | |a Kelsie Cowman |e author |
| 700 | 1 | 0 | |a Rachel Bartash |e author |
| 700 | 1 | 0 | |a Brenda I. Anosike |e author |
| 700 | 1 | 0 | |a Priya Nori |e author |
| 245 | 0 | 0 | |a Expanding the scope and visibility of ambulatory stewardship programs with novel coronavirus disease 2019 (COVID-19) therapeutics |
| 260 | |b Cambridge University Press, |c 2022-01-01T00:00:00Z. | ||
| 500 | |a 10.1017/ash.2022.52 | ||
| 500 | |a 2732-494X | ||
| 520 | |a Antimicrobial stewardship programs (ASPs) can be expanded to the outpatient setting to serve as a first line of defense against coronavirus disease 19 (COVID-19) hospitalizations and to reduce the burden on emergency departments and acute-care hospitals. Given the numerous emergency use authorizations of monoclonal antibodies and oral antivirals, ASPs possess the expertise and leadership to direct ambulatory COVID-19 initiatives and transform it into a predominantly outpatient illness. In this review, we summarize the critical role and benefits of an ASP-championed ambulatory COVID-19 therapeutics program. | ||
| 546 | |a EN | ||
| 690 | |a Infectious and parasitic diseases | ||
| 690 | |a RC109-216 | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022) | |
| 787 | 0 | |n https://www.cambridge.org/core/product/identifier/S2732494X22000523/type/journal_article | |
| 787 | 0 | |n https://doaj.org/toc/2732-494X | |
| 856 | 4 | 1 | |u https://doaj.org/article/c09c7d8a80e64884a0e88eba8cf5e006 |z Connect to this object online. |